Neuralink’s brain machine interface develops solutions for victims of paralysis, but experts believe it could take several years before the company will receive clearance for commercial use.
Electric carmaker Tesla CEO Elon Musk meets with French Minister for the Economy and Finances Bruno Le Maire on the sidelines of the 6th edition of the"Choose France" Summit at the Chateau de Versailles, outside Paris on May 15, 2023. Following the trial's approval, however, Neuralink shares were marketed privately to investors in recent days at a $7 billion valuation, equivalent to $55 per share, according to an email seen by Reuters.
While Neuralink executives and Musk have not responded to requests for comment, Musk has said the company’s chip would allow healthy and disabled people alike to stop by neighborhood facilities for prompt surgical insertions to treat obesity, autism, depression and schizophrenia. Musk also said he sees them being used for web-surfing and telepathy.
A Neuralink executive recently gave more modest short-term objectives, such as helping paralyzed patients communicate through computerized text without typing.Neuralink's initial request for a human trial was rejected by the FDA last year, citing safety concerns. Since then, Musk’s startup has been scrutinized by U.S. lawmakers after its animal-research board possibly violated conflict-of-interest regulations.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: Reuters - 🏆 2. / 97 Weiterlesen »
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »